Previous 10 | Next 10 |
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow PR Newswire SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform compan...
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store PR Newswire SHANGHAI , Feb. 16, 2023 /PRNewswire/ -- On February 15, 2023 , 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China , ...
Summary Merger arbitrage spreads are wide. There are plenty of opportunities with spreads of up to 81%. This is a detailed review of the most interesting transactions in the space. Merger arbitrage is an event-driven investment strategy of betting on a successful acquisiti...
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results PR Newswire SHANGHAI , Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting pati...
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow PR Newswire SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform ...
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee PR Newswire SHANGHAI , Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform ...
Online drug retailer 111 ( NASDAQ: YI ) said its board received an unsolicited preliminary non-binding proposal letter to acquire the company to take it private. The Chinese company received the proposal from its Co-Founder and Co-Chairman Gang Yu, Co-Founder,...
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company PR Newswire SHANGHAI , Sept. 9, 2022 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China , ...
111, Inc. (YI) Q2 2022 Earnings Conference Call August 25, 2022, 07:30 AM ET Company Participants Monica Mu - Investor Relations Director Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Ch...
The following slide deck was published by 111, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: 111, Inc. 2022 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024 PR Newswire SHANGHAI July 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the ...
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility PR Newswire SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare plat...
111, Inc. Announces First Quarter 2024 Unaudited Financial Results PR Newswire Turned to Quarterly Operational Profitability for the First Time Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% Achieved Positive Operating C...